The company has been improving manufacturing processes and fixed costs over four years and could expect to see 8 to 10 percent free cash flow yield, according to the report.
Zimmer has also been investing in emerging markets, such as China and India.
More Articles on Devices:
American Spine Expands to Gettysburg
Miami Project to Cure Paralysis Successfully Transplants Human Cells for Spinal Cord Injury
Outlook for Spinal Non-Fusion Technology Trends: Q&A with Joe Ross of LDR
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
